Optimized antimicrobial peptide jelleine-i derivative br-j-i inhibits fusobacterium nucleatum to suppress colorectal cancer progression

HIGHLIGHTS

• who: Fengjing Jia and colleagues from the Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China have published the research work: Optimized Antimicrobial Peptide Jelleine-I Derivative Br-J-I Inhibits Fusobacterium Nucleatum to Suppress Colorectal Cancer Progression, in the Journal: (JOURNAL)
• what: This study provides a novel approach for the clinical treatment of CRC, in which AMPs can be used as adjuvant therapy to eliminate the adverse effects of pathogenic intestinal bacteria on CRC.
• how: The results showed that the halogenated J-I derivatives had better antimicrobial activity than . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.